Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Phase III extension studies show long-term benefit of NX-1207 in BPH

July 29, 2015

EMA committee recommends approval of Fexeric

July 27, 2015

Vidasym's phosphate binder VS-505 enters phase I/II trial

July 23, 2015

Gilead patents MAP3K5 inhibitors

July 20, 2015

ErepoXen increases hemoglobin levels to therapeutic range in phase II trial

July 16, 2015

Merck & Co. divulges ROMK channel blockers

July 15, 2015

Aquinox Pharmaceuticals reports data from LEADERSHIP trial

June 26, 2015

Eppin Pharma receives NIH grant to develop non-hormonal male contraceptive

June 19, 2015

Angion Biomedica to begin phase II trial of BB3 in acute kidney injury

June 10, 2015

Regulus Therapeutics starts phase I trial of Alport syndrome candidate RG-012

June 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...